Predicta Biosciences - About the company
Predicta Biosciences is a series A company based in Boston (United States), founded in 2023 by Gad Getz, Irene Ghobrial and Ken Anderson. It operates as a Provider of diagnostic and therapeutic products for oncology. Predicta Biosciences has raised $28.6M in funding from Engine Ventures. The company has 91 active competitors, including 37 funded and 13 that have exited. Its top competitors include companies like Personalis, ACT Genomics and 4baseCare.
Company Details
Provider of diagnostic and therapeutic products for oncology. It offers a non-invasive diagnostics focus on multiple myeloma and evaluate patients’ immune system cells to determine the patient responding to immunotherapies.
Key Metrics
Founded Year
2023
Location
Boston, United States
Stage
Series A
Total Funding
$28.6M in 2 rounds
Latest Funding Round
Investors
Ranked
7th among 91 active competitors
Employee Count
19 as on Apr 30, 2026
Similar Companies
Sign up to download Predicta Biosciences' company profile
Predicta Biosciences's funding and investors
Predicta Biosciences has raised a total funding of $28.6M over 2 rounds. Its first funding round was on Jul 16, 2024. Its latest funding round was a Series A round on Oct 01, 2025 for $*****. 6 investors participated in its latest round. Predicta Biosciences has 9 institutional investors.
Here is the list of recent funding rounds of Predicta Biosciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 01, 2025 | 2474285 | Series A | 8326028 | 9882992 | 5244065 | 9249340 |
Jul 16, 2024 | 2083721 | Seed | 6822307 | 7200996 |
Access funding benchmarks and valuations. Sign up today!View details of Predicta Biosciences's funding rounds and investors
Predicta Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Predicta Biosciences are Gad Getz, Irene Ghobrial and Ken Anderson. Kate Caves is the CEO of Predicta Biosciences.
Here are the details of Predicta Biosciences' key team members:
- Gad Getz: Co-Founder of Predicta Biosciences. Contact Info: 3 email addresses
- Irene Ghobrial: Co-Founder of Predicta Biosciences.
- Ken Anderson: Co-Founder of Predicta Biosciences.
- Kate Caves: CEO of Predicta Biosciences. Contact Info: 1 email address
View details of Predicta Biosciences's Founder profiles and Board Members
Predicta Biosciences' employee count trend
Predicta Biosciences has 19 employees as of Apr 26. Here is Predicta Biosciences's employee count trend over the years:
Uncover Predicta Biosciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Predicta Biosciences's Competitors and alternates
Top competitors of Predicta Biosciences include Personalis, ACT Genomics and 4baseCare. Here is the list of Top 10 competitors of Predicta Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Personalis 2011, Menlo Park (United States), Public | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 70/100 | |
2nd | _1582012509394.png?devicePixelRatio=2&height=30&width=30){kind=logo} ACT Genomics 2014, Taipei (Taiwan), Acquired | Clinical and research services in genomics for cancer | $20.5M | 64/100 | |
3rd | Provider of precision oncology solutions, including genomic testing and digital health | $22.3M | 63/100 | ||
4th | Personal Genome 2010, Baltimore (United States), Acquired | Provider of advanced technology solutions for cancer genome analysis | $327M | 61/100 | |
5th |  Precede 2021, Boston (United States), Series C | Developer of liquid biopsy platform providing disease-defining biology from blood tests | $57M | 60/100 | |
6th |  Xcell Biosciences 2012, San Francisco (United States), Series B | Developer of cell culture analysis device for cancer research | $40.9M | 60/100 | |
7th | Predicta Biosciences 2023, Boston (United States), Series A | Provider of diagnostic and therapeutic products for oncology | $28.6M | 59/100 | |
8th | Developer of cancer cell capture and analysis equipment | - | 57/100 | ||
9th |  Olaris 2014, Waltham (United States), Series B | Developer of in-vitro diagnostics for oncology, solid-organ transplant, and neurodegeneration | $62.5K | 55/100 | |
10th | Epredia 2019, United Kingdom, Unfunded | Developer of in-vitro diagnostic test for cancer | - | - | 54/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Predicta Biosciences's competitors? Click here to see the top ones
Predicta Biosciences's Investments and acquisitions
Predicta Biosciences has made no investments or acquisitions yet.
News related to Predicta Biosciences
Media has covered Predicta Biosciences for a total of 4 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
•
Predicta Biosciences Appoints Dr. Craig L. Tendler as Independent Director to its BoardBusiness Wire•May 20, 2026•Predicta Biosciences
•
•
Predicta Biosciences Completes $23.4 Million Series A Financing RoundGlobal Legal Chronicle•Oct 09, 2025•Predicta Biosciences
•
Predicta Biosciences Raises $23.4M in Series A FundingFinSMEs•Oct 02, 2025•BrightEdge, Predicta Biosciences, Mass General Brigham, Engine Ventures and 5 others
•
Predicta Biosciences Launches First Molecular Diagnostic ProductBusiness Wire•Apr 30, 2025•Predicta Biosciences
•
Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood CancersBusiness Wire•Jul 16, 2024•Predicta Biosciences, Engine Ventures, Illumina Ventures, Time Partners and 2 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Predicta Biosciences
Explore our recently published companies
- Juno Industries - Ottawa based, Seed company
- Ryan Litfin - Eden Prairie based, 2008 founded, Seed company
- Cigenergy - Shenzhen based, 2014 founded, Funding Raised company
- National Commodity & Derivatives Exchange - Mumbai based, 2003 founded, Series B company
- Raj Petro Specialities - Chennai based, 1997 founded, Acquired company
- Valvoline - Lexington based, 1866 founded, Unfunded company
